MA
BIIB icon

MONECO Advisors’s Biogen BIIB Stock Holding History

MONECO Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Buy
1,480
+44
+3% +$8.42K 0.02% 461
2026
Q1 		$263K Buy
1,436
+17
+1% +$3.13K 0.02% 440
2025
Q4 		$250K Buy
+1,419
New +$232K 0.02% 439
2025
Q1 		– Sell
-1,341
Closed -$205K – 459
2024
Q4 		$205K Buy
+1,341
New +$226K 0.02% 451

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MONECO Advisors's BIIB Position: Q2 2026 in Review

MONECO Advisors increased its Biogen (BIIB) stake by 3.1% in Q2 2026, buying an estimated $8.42K and bringing the position to 1,480 shares worth $320K. The position accounts for 0.02% of the portfolio, ranked #461.

MONECO Advisors first reported a position in BIIB in Q4 2024 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • MONECO Advisors held 1,480 shares of Biogen worth $320K as of Q2 2026.
  • MONECO Advisors bought 44 Biogen shares in Q2 2026, an estimated $8.42K.
  • Biogen made up 0.02% of MONECO Advisors's portfolio in Q2 2026, its #461 holding.
  • MONECO Advisors first reported a position in Biogen in Q4 2024 and has held it in 4 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.